Table 6.
Compound No. | R2 | EC50 (μM) | CC50 (μM) |
---|---|---|---|
214 | 0.759 | 20.80 | |
215 | Ph | 0.865 | 20.80 |
216 | 2-Cl-Ph | 2.014 | 20.80 |
217 | 3-Cl-Ph | 0.977 | 6.40 |
218 | 4-Cl-Ph | >100 | 6.60 |
219 | COCH3 | 0.317 | >100 |
220 | COCH2CH3 | 3.090 | >100 |
221 | COCH(CH3)2 | 0.847 | >100 |
222 | COCH2CH(CH3)2 | 1.884 | >100 |
223 | CO(c-Hexyl) | 9.240 | >100 |
224 | COPh | 0.570 | >100 |
225 | COCH2Ph | 0.079 | >100 |
226 | COCH2CH2Ph | 0.464 | >100 |
227 | SO2CH3 | 2.272 | >100 |
228 | SO2Ph | 1.166 | 20.50 |
aEC50: the concentration of compound that reduced 50% of the cytopathic effect of RSV. Long strain infected HEp-2 cells. CC50: the concentration of compound that manifests cytotoxicity toward 50% of uninfected HEp-2 cells. Values are means of at least two experiments performed in consecutive weeks.